SHELDON JORDAN: Open Payments
NPI 1316941305 · SANTA MONICA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,561 in 232 payments from 41 companies in 2025. Trend: 2023 $4,930 · 2024 $5,272 · 2025 $5,561
Food & beverage: $5,537Education: $23
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $710 |
| CSL Behring | 28 | $559 |
| Axsome Therapeutics, Inc. | 14 | $297 |
| Lundbeck LLC | 12 | $290 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $286 |
| UCB, Inc. | 20 | $274 |
| REVANCE THERAPEUTICS, INC. | 4 | $213 |
| HARMONY BIOSCIENCES LLC | 8 | $196 |
| E.R. Squibb & Sons, L.L.C. | 10 | $175 |
| Genentech USA, Inc. | 5 | $169 |
Products named: Hizentra, VRAYLAR, CAPLYTA, QULIPTA, REXULTI, Leqembi, DAXXIFY, WAKIX.
Industry payments across CA — which companies pay providers there.
